Cargando…

Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective

PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Daniel, Greenberg, Arieh, Maliarov, Anton, Seligman, David, Backstein, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Paris 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009351/
https://www.ncbi.nlm.nih.gov/pubmed/36912950
http://dx.doi.org/10.1007/s00590-023-03514-0
_version_ 1784905965035847680
author Cohen, Daniel
Greenberg, Arieh
Maliarov, Anton
Seligman, David
Backstein, David
author_facet Cohen, Daniel
Greenberg, Arieh
Maliarov, Anton
Seligman, David
Backstein, David
author_sort Cohen, Daniel
collection PubMed
description PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single surgeon. METHODS: Data from patients treated with the NexGen PS TKA between January 2003 and December 2005 with a minimal follow-up of 15 years was collected from a prospectively collected database. Survivorship rates and Oxford Knee Scores (OKS) were obtained for those patients available for follow-up. RESULTS: Ninety-five patients met the inclusion criteria during the study period. OKS was available for 44 (46%) patients. Ten patients required revision surgery (10.52%). Implant-specific survivorship of all cases that were reviewed was 98%. Survivorship of implants in patients that we were able to reach, or deceased patients was 93%. The average Oxford Knee Score was 39.1 (14–48. SD ± 7.70) with 48 being the maximal score. CONCLUSION: Despite some concerns about durability of this implant, good longevity and function was demonstrated. At a minimum of 15 years follow-up in this cohort. Given these results design features of this system should be considered for future generations of implants.
format Online
Article
Text
id pubmed-10009351
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Paris
record_format MEDLINE/PubMed
spelling pubmed-100093512023-03-13 Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective Cohen, Daniel Greenberg, Arieh Maliarov, Anton Seligman, David Backstein, David Eur J Orthop Surg Traumatol Original Article PURPOSE: Studying long-term survivorship and functional outcomes for specific prostheses is critical for elucidating areas in need of design improvement. This study reports the long-term of the NexGen Posterior Stabilized (PS) Total Knee implant (TKA) (Zimmer Biomet, Warsaw IN) Performed by a single surgeon. METHODS: Data from patients treated with the NexGen PS TKA between January 2003 and December 2005 with a minimal follow-up of 15 years was collected from a prospectively collected database. Survivorship rates and Oxford Knee Scores (OKS) were obtained for those patients available for follow-up. RESULTS: Ninety-five patients met the inclusion criteria during the study period. OKS was available for 44 (46%) patients. Ten patients required revision surgery (10.52%). Implant-specific survivorship of all cases that were reviewed was 98%. Survivorship of implants in patients that we were able to reach, or deceased patients was 93%. The average Oxford Knee Score was 39.1 (14–48. SD ± 7.70) with 48 being the maximal score. CONCLUSION: Despite some concerns about durability of this implant, good longevity and function was demonstrated. At a minimum of 15 years follow-up in this cohort. Given these results design features of this system should be considered for future generations of implants. Springer Paris 2023-03-13 /pmc/articles/PMC10009351/ /pubmed/36912950 http://dx.doi.org/10.1007/s00590-023-03514-0 Text en © The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature 2023, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Cohen, Daniel
Greenberg, Arieh
Maliarov, Anton
Seligman, David
Backstein, David
Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title_full Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title_fullStr Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title_full_unstemmed Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title_short Long-term outcomes of the Nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
title_sort long-term outcomes of the nexgen(©) posterior stabilized knee: minimum 15 year follow—safe and effective
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009351/
https://www.ncbi.nlm.nih.gov/pubmed/36912950
http://dx.doi.org/10.1007/s00590-023-03514-0
work_keys_str_mv AT cohendaniel longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective
AT greenbergarieh longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective
AT maliarovanton longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective
AT seligmandavid longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective
AT backsteindavid longtermoutcomesofthenexgenposteriorstabilizedkneeminimum15yearfollowsafeandeffective